393 related articles for article (PubMed ID: 35570845)
1. Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders.
Fanizza F; Campanile M; Forloni G; Giordano C; Albani D
J Tissue Eng; 2022; 13():20417314221095339. PubMed ID: 35570845
[TBL] [Abstract][Full Text] [Related]
2. Drug discovery using induced pluripotent stem cell models of neurodegenerative and ocular diseases.
Hung SSC; Khan S; Lo CY; Hewitt AW; Wong RCB
Pharmacol Ther; 2017 Sep; 177():32-43. PubMed ID: 28223228
[TBL] [Abstract][Full Text] [Related]
3. Organs-on-chip: The way forward.
Mastrangeli M; van den Eijnden-van Raaij J
Stem Cell Reports; 2021 Sep; 16(9):2037-2043. PubMed ID: 34297941
[TBL] [Abstract][Full Text] [Related]
4. iPSC-derived organ-on-a-chip models for personalized human genetics and pharmacogenomics studies.
Palasantzas VEJM; Tamargo-Rubio I; Le K; Slager J; Wijmenga C; Jonkers IH; Kumar V; Fu J; Withoff S
Trends Genet; 2023 Apr; 39(4):268-284. PubMed ID: 36746737
[TBL] [Abstract][Full Text] [Related]
5. Evolution of Biochip Technology: A Review from Lab-on-a-Chip to Organ-on-a-Chip.
Azizipour N; Avazpour R; Rosenzweig DH; Sawan M; Ajji A
Micromachines (Basel); 2020 Jun; 11(6):. PubMed ID: 32570945
[TBL] [Abstract][Full Text] [Related]
6. Multiorgan-on-a-Chip: A Systemic Approach To Model and Decipher Inter-Organ Communication.
Picollet-D'hahan N; Zuchowska A; Lemeunier I; Le Gac S
Trends Biotechnol; 2021 Aug; 39(8):788-810. PubMed ID: 33541718
[TBL] [Abstract][Full Text] [Related]
7. Human-Derived Organ-on-a-Chip for Personalized Drug Development.
Jodat YA; Kang MG; Kiaee K; Kim GJ; Martinez AFH; Rosenkranz A; Bae H; Shin SR
Curr Pharm Des; 2018; 24(45):5471-5486. PubMed ID: 30854951
[TBL] [Abstract][Full Text] [Related]
8. Vascular organs-on-chip made with patient-derived endothelial cells: technologies to transform drug discovery and disease modeling.
Whitworth CP; Polacheck WJ
Expert Opin Drug Discov; 2024 Mar; 19(3):339-351. PubMed ID: 38117223
[TBL] [Abstract][Full Text] [Related]
9. Current overview of induced pluripotent stem cell-based blood-brain barrier-on-a-chip.
Alves ADH; Nucci MP; Ennes do Valle NM; Missina JM; Mamani JB; Rego GNA; Dias OFM; Garrigós MM; de Oliveira FA; Gamarra LF
World J Stem Cells; 2023 Jun; 15(6):632-653. PubMed ID: 37424947
[TBL] [Abstract][Full Text] [Related]
10. Progress, obstacles, and limitations in the use of stem cells in organ-on-a-chip models.
Wnorowski A; Yang H; Wu JC
Adv Drug Deliv Rev; 2019 Feb; 140():3-11. PubMed ID: 29885330
[TBL] [Abstract][Full Text] [Related]
11. Potential of Drug Efficacy Evaluation in Lung and Kidney Cancer Models Using Organ-on-a-Chip Technology.
Hwang SH; Lee S; Park JY; Jeon JS; Cho YJ; Kim S
Micromachines (Basel); 2021 Feb; 12(2):. PubMed ID: 33669950
[TBL] [Abstract][Full Text] [Related]
12. Human induced pluripotent stem cell-derived liver-on-a-chip for studying drug metabolism: the challenge of the cytochrome P450 family.
Tamargo-Rubio I; Simpson AB; Hoogerland JA; Fu J
Front Pharmacol; 2023; 14():1223108. PubMed ID: 37448965
[TBL] [Abstract][Full Text] [Related]
13. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
Corti S; Faravelli I; Cardano M; Conti L
Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Development in Organ-On-A-Chip Technology.
Joseph X; Akhil V; Arathi A; Mohanan PV
J Pharm Sci; 2022 Jan; 111(1):18-31. PubMed ID: 34324944
[TBL] [Abstract][Full Text] [Related]
15. Advances in Organ-on-a-Chip Materials and Devices.
Nahak BK; Mishra A; Preetam S; Tiwari A
ACS Appl Bio Mater; 2022 Aug; 5(8):3576-3607. PubMed ID: 35839513
[TBL] [Abstract][Full Text] [Related]
16. Reverse engineering human neurodegenerative disease using pluripotent stem cell technology.
Liu Y; Deng W
Brain Res; 2016 May; 1638(Pt A):30-41. PubMed ID: 26423934
[TBL] [Abstract][Full Text] [Related]
17. Mimicking the Kidney: A Key Role in Organ-on-Chip Development.
Paoli R; Samitier J
Micromachines (Basel); 2016 Jul; 7(7):. PubMed ID: 30404298
[TBL] [Abstract][Full Text] [Related]
18. Organ-On-Chip Technology: The Future of Feto-Maternal Interface Research?
Richardson L; Kim S; Menon R; Han A
Front Physiol; 2020; 11():715. PubMed ID: 32695021
[TBL] [Abstract][Full Text] [Related]
19. Revolutionizing nephrology research: expanding horizons with kidney-on-a-chip and beyond.
Huang W; Chen YY; He FF; Zhang C
Front Bioeng Biotechnol; 2024; 12():1373386. PubMed ID: 38605984
[TBL] [Abstract][Full Text] [Related]
20. The Power and the Promise of Cell Reprogramming: Personalized Autologous Body Organ and Cell Transplantation.
Palomo AB; Lucas M; Dilley RJ; McLenachan S; Chen FK; Requena J; Sal MF; Lucas A; Alvarez I; Jaraquemada D; Edel MJ
J Clin Med; 2014 Apr; 3(2):373-87. PubMed ID: 26237380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
